• LAST PRICE
    0.5022
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.5500/ 7
  • Ask / Lots
    0.5800/ 77
  • Open / Previous Close
    0.0000 / 0.5022
  • Day Range
    ---
  • 52 Week Range
    Low 0.2999
    High 9.1700
  • Volume
    26,368
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.5699
TimeVolumeFRES
09:32 ET1490.5963
09:34 ET20000.5787
09:36 ET31000.5444
09:38 ET45120.514
09:39 ET1000.5103
09:41 ET5000.5103
09:43 ET5360.5011
09:45 ET19470.502
09:56 ET10000.5145
10:06 ET1000.5144
10:14 ET5000.5701
10:24 ET1000.584447
10:26 ET7000.5693
10:35 ET73560.5547
10:51 ET1000.5547
10:53 ET9500.5177
11:06 ET2000.5434
11:26 ET2000.54
11:31 ET12000.54
11:40 ET34000.5363
12:03 ET1670.5363
12:12 ET1000.52
12:18 ET9870.5145
12:23 ET12250.5152
12:27 ET48120.5151
12:38 ET9820.5493
01:19 ET7350.5493
01:24 ET1670.5493
02:06 ET1000.5493
02:09 ET4550.5493
02:54 ET1670.5493
03:05 ET20000.5144
03:14 ET10000.5145
03:48 ET8410.5144
03:52 ET10000.51
03:54 ET1000.5022
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFRES
Fresh2 Group Ltd
16.4M
-0.1x
---
United StatesHIGR
Hi-Great Group Holding Co
1.8M
148.3x
---
United StatesRGBP
Regen BioPharma Inc
2.9M
-2.0x
---
United StatesACON
Aclarion Inc
2.1M
0.0x
---
United StatesCPMV
Mosaic Immunoengineering Inc
2.3M
-2.2x
---
United StatesCNSP
CNS Pharmaceuticals Inc
2.3M
0.0x
---
As of 2024-04-30

Company Information

AnPac Bio-Medical Science Co Ltd is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States. The Company is also engaged in providing technical solution and outsourcing consulting service focusing on the digital, internet, and Web3 transformation of start-ups and traditional enterprises.

Contact Information

Headquarters
801 Bixing Street, Bihu CountyLishui, ZHJ, China F4 323006
Phone
---
Fax
---

Executives

Co-Chairman of the Board, Co-Chief Executive Officer
Aidong Chen
Co-Chairman of the Board, Co-Founder
Chang Yu
Co-Founder, Chief Medical officer
Herbert Yu
Chief Financial Officer
Jinqiu Tang
President, China
Weidong Dai

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$16.4M
Revenue (TTM)
$1.6M
Shares Outstanding
32.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.46
EPS
$-4.04
Book Value
$-0.54
P/E Ratio
-0.1x
Price/Sales (TTM)
10.1
Price/Cash Flow (TTM)
---
Operating Margin
-825.97%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.